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Summary
Fluorescence imaging of living cells depends on an
efficient and specific method for labeling the target
cellular protein with fluorophores. Here we show that
Sfp phosphopantetheinyl transferase-catalyzed pro-
tein labeling is suitable for fluorescence imaging of
membrane proteins that spend at least part of their
membrane trafficking cycle at the cell surface. In this
study, transferrin receptor 1 (TfR1) was fused to pep-
tide carrier protein (PCP), and the TfR1-PCP fusion
protein was specifically labeled with fluorophore
Alexa 488 by Sfp. The trafficking of transferrin-TfR1-
PCP complex during the process of transferrin-medi-
ated iron uptake was imaged by fluorescence reso-
nance energy transfer between the fluorescently
labeled transferrin ligand and TfR1 receptor. We thus
demonstrated that Sfp-catalyzed small molecule la-
beling of the PCP tag represents a practical and effi-
cient tool for molecular imaging studies in living
cells.
Introduction
Real-time visualization of cellular events is critical for
elucidating the complex mechanism of biological pro-
cesses at the molecular level. To date, much of cellular
protein labeling and visualization has been accom-
plished by expressing the protein of interest as a fusion
to the green fluorescent protein (GFP) or its variants in
order to study protein localization and dynamics in the
living cell [1, 2]. Although GFP and related derivatives
bear the drawbacks of large size (230 residues, 27 kDa),
limited number of fluorescent variants, and relatively
low intrinsic brightness, they are nevertheless the most
extensively used fluorescent probes for protein label-
ing, mainly because they can be genetically encoded
and expressed as fusions to the target protein. Despite
the development of many synthetic fluorescent probes,
from small molecules to nanocrystal quantum dots [3],
with excellent sensitivity and resolution for fluorescence*Correspondence: wessling@hsph.harvard.edu (M.W.-R.); dgolan@
hms.harvard.edu (D.E.G.); christopher_walsh@hms.harvard.edu (C.T.W.)
3 These authors contributed equally to this work.microscopy, the lack of efficient labeling methods to
enable specific conjugation of the synthetic probes to
the target protein in the context of a living cell reduces
the potential utility of the synthetic probe toolbox.
Several strategies for labeling proteins with small
molecules in the living cell [4] have been developed
based on noncovalent binding of small molecule probes
to an oligo histidine tag [5], a single-chain antibody
fragment [6], or dihydrofolate reductase [7] fused to the
protein of interest. However, noncovalent interaction
between the probes and binding partners does not
yield a stable complex and inevitably leads to signal
deterioration with time as the probes progressively dis-
sociate from the target protein. Although a covalent la-
beling method is preferable, currently available meth-
ods suffer drawbacks. For example, biarsenical dyes
[8] have been used for site-specific labeling of the
CCXXCC motif fused to the target protein, but the cell
needs to be treated with micromolar concentrations of
dithiols during the labeling reaction, and the back-
ground labeling is high [9]. In another method, human
O6-alkylguanine-DNA alkyltransferase (hAGT) is fused
to the target protein, and protein labeling is achieved
by transferring the alkyl group of an O6-alkylguanine
derivative to a cysteine residue on hAGT [10]. The main
drawback of this method is that the size of hAGT is
large (207 residues) and hAGT-deficient cell lines need
to be used for protein labeling. A recent report showed
that biotin ligase can be used to transfer biotin to a 15
residue peptide fused to the target protein, which can
then be labeled with fluorophores conjugated to strep-
tavidin. Although in this case the size of the peptide tag
is small, a multistep procedure involving streptavidin
binding must be performed in order to label cell surface
receptors with fluorophores [11].
We recently developed a general strategy for site-
specific labeling of proteins with small molecules by
the posttranslational modification enzyme phospho-
pantetheinyl transferase Sfp [12]. The target proteins
are expressed as fusions to an 80 residue peptide car-
rier protein (PCP) excised from a nonribosomal peptide
synthetase (NRPS), such that Sfp catalyzes the cova-
lent modification of a specific serine residue on PCP to
yield the small molecule-phosphopantetheinyl conju-
gate. The specific and efficient labeling reaction targets
PCP fusion proteins in cell lysates. The PCP tag has
been shown to be compatible with diverse proteins,
and Sfp-catalyzed PCP modification can be carried out
with various small molecule probes conjugated to co-
enzyme A (CoA) [13, 14], highlighting the potential of
the PCP tag for site-specific protein labeling with small
molecules. Similar to this strategy, it was reported re-
cently that a-agglutinin receptor and G protein-coupled
receptor neurokinin-1 could be fused to the acyl carrier
protein from E. coli and specifically labeled with fluoro-
phores by E. coli phosphopantetheinyl transferase [15].
Here we describe the application of the Sfp-cata-
lyzed protein labeling strategy for imaging the endo-
cytic pathway of transferrin receptor 1 (TfR1). More-
over, we show that, by specific labeling of TfR1 and
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1000transferrin with a pair of small molecule fluorophores
(Alexa Fluor 488 and 568) suitable for the measurement
of fluorescence resonance energy transfer (FRET) [16],
internalization of the ligand-receptor complex can be
followed by FRET between TfR1 and transferrin. This
method enables the tracking of receptor-ligand com-
plex formation, endocytosis, and exocytosis in real
time, further demonstrating the potential of Sfp-cata-
lyzed protein labeling for live-cell imaging.
Results and Discussion
Transferrin-mediated iron uptake represents the major
mechanism used by vertebrate cells to acquire iron
from the environment [17, 18]. Upon binding of diferric
transferrin to TfR1, internalization of the holo transfer-
rin-TfR1 complex occurs through clathrin-dependent
endocytosis. The holo transferrin-TfR1 complexes are
first delivered to early endosomes, where transferrin re-
leases iron within an acidic environment. Apotransferrin
then remains bound to TfR1 until the complex recycles
back to the cell surface, where it dissociates at a neu-
tral pH [19, 20] (Figure 1).
TfR1 is a homodimeric type II transmembrane protein
with a small N-terminal cytoplasmic domain, a single-
pass transmembrane region, and a large extracellular
domain [21, 22]. Recent structural analysis of the hu-
man TfR1-transferrin complex, obtained by cryo-EM,
has revealed that each TfR1 dimer binds two transfer-
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Transferrin receptor 1 (green) is drawn with C terminus fused to the PCP domain (blue), and transferrin ligand is shown as red triangles with
iron (gray balls) bound. For fluorescence imaging, transferrin receptor 1 was labeled with Alexa 488 (green oval) attached to the PCP, and
transferrin was labeled with Alexa 568 (red circle).ins with a two-fold symmetry and that the extracellular
terminus of TfR1 is not involved in the binding of
ransferrin to TfR1 [23] (Figure 2). We thus rationalized
hat attachment of the PCP tag to the C terminus of
fR1 would not interfere with ligand binding, such that
he TfR1-PCP fusion should remain functional in
ransferrin-mediated iron uptake. By fusing the PCP tag
o the C terminus of TfR1, PCP would also be anchored
n the surface of the cell and would therefore be avail-
ble for the protein labeling reaction catalyzed by exog-
nously added Sfp.
onstruction and Biochemical Characterization
f TfR1-PCP Fusion Receptor
CP from gramicidin NRPS [12] was fused to the C ter-
inus of TfR1 cloned into the plasmid pcDNA3.1(+) TfR
24] to generate plasmid pcDNA3.1(+) TfR1-PCP. TRVb
ells [25], a Chinese hamster ovary cell line that lacks
ndogenous TfR1, were used for stable expression of
fR1-PCP upon cotransfection with pcDNA3.1(+) TfR1-
CP and pBABE carrying a puromycin resistance gene.
RVb/TfR1-PCP cells were established using puromy-
in selection.
To functionally characterize the TfR1-PCP fusion re-
eptor, 55Fe uptake and 125I-labeled diferric transferrin
inding studies were performed. Results on TRVb/
fR1-PCP cells were compared to those on TRVb cells,
he parental line, as well as TRVb1 cells, which stably
xpress wild-type TfR1 [25]. As shown in Figure 3A,
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1001Figure 2. Sfp-Catalyzed Labeling of TfR1-PCP Fusion on the Surface of the Cell
Biotin and Alexa Fluor 488 are conjugated to CoA (1 and 2), and Sfp catalyzes the specific modification of a conserved serine residue on the
PCP (red ribbon) by the phosphopantetheinyl group attached to the small molecule labels. PCP is shown fused to the C terminus (red) of the
extracellular domain (blue) of TfR1 with its N terminus and transmembrane domain in green. Transferrin (gray) binds to TfR1 with a 2-fold
symmetry. The structure of transferrin-TfR1 complex was adapted from [23].when incubated with 55Fe-transferrin, TRVb/TfR1-PCP
cells took up levels of 55Fe similar to those of TRVb1
cells, and both cell lines had significantly higher 55Fe
uptake (>4-fold) than TRVb cells with no endogenous
TfR1 expression. Western blot analysis confirmed sim-
ilar expression levels of TfR1 and TfR1-PCP in the
TRVb1 cells and TRVb/TfR1-PCP cells, respectively.
Thus, the fusion receptor TfR1-PCP is capable of deliv-
ering 55Fe bound transferrin to the cell. To characterize
the physical interaction between ligand and receptor,
surface binding of 125I-labeled diferric transferrin to the
TRVb/TfR1-PCP and TRVb1 cell lines was measured
(Figure 3B). For both cell lines, transferrin binding was
saturable with respect to transferrin concentrations up
to 500 nM. Based on a 1:1 binding model, the dissoci-
ation constants (Kd) of diferric transferrin for TfR1-PCP
fusion and wild-type TfR1 on the cell surface were calcu-
lated to be 13.9 ± 0.6 nM and 3.4 ± 3.7 nM, respectively.
Thus, although the affinity of TfR1-PCP for transferrin was
lower than that of wild-type TfR1, transferrin-mediated
55Fe uptake by the TfR1-PCP receptor was not signifi-
cantly impaired.
Live-Cell Labeling of TfR1-PCP by Sfp
To test the labeling of TfR1-PCP fusion receptor ex-
pressed on the surface of TRVb/TfR1-PCP cells with
Sfp, biotin-CoA (1) and Sfp were added to the cell me-dia and the labeling reaction was allowed to proceed
for 20 min. After washing, the cells were lifted from the
tissue culture plate and cell lysates were prepared for
polyacrylamide gel electrophoresis (PAGE) under both
nonreducing and reducing conditions. After electropho-
resis, protein was transferred to PVDF membrane and
blots were probed using horseradish peroxidase (HRP)-
conjugated streptavidin (Figure 4). Under nonreducing
conditions, a strong band at 190 kDa was observed,
the size of TfR1-PCP homodimer. Reducing conditions
yielded a strong band at 95 kDa, the size of TfR1-PCP
monomer, while the band at 190 kDa disappeared.
These results indicated that TfR1-PCP was efficiently
labeled, and the labeling reaction did not disrupt recep-
tor dimerization. Control experiments, carried out with
either biotin-CoA or Sfp excluded from the labeling re-
action, failed to produce specific labeling. Two faint
bands migrating slightly above and below the TfR1-
PCP monomer at 95 kDa, which were observed in the
absence of biotin-CoA or Sfp, were also present in con-
trol labeling reactions using the TRVb cells with no TfR1
expressed, and were most likely cellular proteins with
streptavidin binding affinity or with biotin attached be-
fore the labeling reaction. The presence of these bands
suggests that one common labeling method using
streptavidin-fluorescent dye conjugates may give artifi-
cial results or high background.
The function of TfR1-PCP was probed further by com-
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1002Figure 3. Functional Characterization of TfR1-PCP Fusion
(A) Cell-associated 55Fe was measured in uptake assays upon incu-
bation of TRVb, TRVb1, and TRVb/TfR1-PCP cells with 40 nM 55Fe-
transferrin, as described in Experimental Procedures. Also shown
is a Western blot for TRVb (1), TRVb1 (2), and TRVb/TfR1-PCP (3)
cell lysates probed with mouse anti-TfR1 antibody.
(B) Surface 125I-transferrin binding was measured for TRVb1 and
TRVb/TfR1-PCP cells incubated on ice with 0.05–500 nM 125I-
transferrin in the presence or absence of excess unlabeled
transferrin. Specific cell surface binding was taken as the differ-
ence between these measured values, and the data were normal-
ized to maximal values determined at 500 nM 125I-transferrin for
each cell line. Binding curves were fit assuming a 1:1 binding
model.
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digure 4. Detection of TfR1-PCP Using Biotin Labeling
RVb/TfR1-PCP or TRVb cells were incubated with or without bio-
in-CoA (1) in the presence and absence of Sfp. Cell lysates were
repared for electrophoresis under both nonreducing (A) and re-
ucing (B) conditions. After transfer to a PVDF membrane, labeling
ith biotin was probed using streptavidin-HRP.paring transferrin uptake pathways in TRVb1 cells and in
TRVb cells transiently transfected with pcDNA3.1(+)
TfR1-PCP. In both cases, cells were incubated with
Alexa Fluor 568 diferric human transferrin conjugates
(Tf-Alexa 568, T-23365; Molecular Probes, Inc., Eugene,
OR) and fixed at different time points for observation
under the confocal microscope. Figure 5 shows a
series of projections of stacks of optical slices taken at
0.25 µm per slice. The top three images show TRVb1
cells 1, 10, and 30 min after the addition of Tf-Alexa
568. At short incubation times, transferrin was ob-
served mainly in the vicinity of the plasma membrane,
while longer incubation with Tf-Alexa 568 resulted in
trafficking of transferrin into the cell and eventual ligand
aggregation. These observations agree with current
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codels for TfR1-mediated transferrin uptake, in which
he ligand is internalized through receptor-mediated
ndocytosis and collected in recycling endosomes be-
ore leaving the cell by exocytosis. Corresponding
mages of TRVb cells transfected with TfR1-PCP
howed a similar time course (Figure 5, bottom), indi-
ating that the mechanism of transferrin uptake medi-
ted by the TfR1-PCP fusion protein was not detectably
ifferent from that mediated by TfR1. Taken together
ith the results of 55Fe uptake and 125I-transferrin binding
tudies, the fluorescence imaging studies suggested
hat addition of the PCP domain did not significantly
lter the function of the receptor.
RET Imaging of TfR1-PCP Endocytosis
pon Transferrin Binding
he small size of the PCP domain and the speed of the
abeling reaction allowed live-cell labeling and facili-
ated dynamic studies of protein-protein interactions.
e were therefore able to apply single-cell FRET im-
ging techniques to study the interaction of transferrin
ith its membrane receptor TfR1-PCP in TRVb cells.
RET refers to the nonradiative transfer of energy be-
ween two fluorophores, where the emission spectrum
f the donor overlaps significantly with the excitation
pectrum of the acceptor. The efficiency of energy
ransfer decreases as the sixth power of the separation
istance between donor and acceptor fluorophores, re-
tricting the detection of protein-protein interactions to
istances of 1–10 nm. The most direct method of quan-
ifying FRET is to measure the increase in acceptor flu-
rescence due to sensitized emission; however, this
ethod is often complicated by signal-to-noise difficul-
ies. We therefore adopted a donor dequenching method
f quantifying FRET, in which the acceptor is photo-
leached and the subsequent recovery of donor fluo-
escence is measured; a partial photobleaching proto-
ol was used to prevent photodamage [26].
TRVb cells lacking endogenous TfR1 were trans-
ected with pcDNA3.1(+) TfR1-PCP, and the expressed
usion receptors were labeled with CoA-conjugated
lexa Fluor 488 (2), the donor fluorophore, in the pres-
nce of Sfp. Cells were then incubated with media con-
aining transferrin labeled with Alexa Fluor 568, the ac-
eptor fluorophore, fixed at different time points, and
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1003Figure 5. Transferrin Uptake Pathway
Cells were incubated with Alexa Fluor 568-
labeled transferrin, fixed at 1, 10, and 30 min
after incubation, and imaged using confocal
microscopy. Stacks of optical slices at 0.25
µm per step were processed by MetaMorph
using 2D no neighbors deconvolution before
3D reconstruction. Top: TRVb1 cells (100%
confluency). Bottom: TRVb cells transfected
with TfR1-PCP prior to the addition of
transferrin (80%–90% confluency); note that
nontransfected cells are not visible. Scale
bar = 10 µm.mounted for imaging. A set of four confocal images was
taken for each field of view and processed using Meta-
Morph to obtain a calculated FRET image [26]. Figure
6 shows a FRET imaging analysis of transferrin ligand-
receptor interactions after 2 min of incubation in the
presence of the ligand. Figures 6A and 6B show the
distribution of TfR1-PCP labeled with Alexa 488 before
and after photobleaching of Alexa 568, respectively,
while Figures 6C and 6D show the distribution of Tf-
Alexa 568 before and after photobleaching of Alexa
568, respectively. The integrated fluorescence inten-
sities of the acceptor Tf-Alexa 568 before and after
photobleaching yielded the factor for partial photo-
bleaching, which was then used to calculate pixel-by-
pixel relative FRET intensities. Finally, the calculated
FRET intensities were reconstructed into an image (Fig-
ure 6E) that revealed the subcellular distribution of
ligand-receptor interactions. Figure 6F shows the over-
lay of Alexa 488-labeled TfR1-PCP (red) after photo-
bleaching of the acceptor, Tf-Alexa 568 (green) before
photobleaching of the acceptor, and calculated FRET
(blue). Linescans of donor fluorescence, acceptor fluo-
rescence, and FRET confirmed that FRET occurred
only where both fluorophores were present (Figure 6G).
A series of FRET imaging analyses allowed tracking
of the interaction and translocation of transferrin and
its receptor over time. As early as 1 min after the addi-
tion of Tf-Alexa 568, a FRET signal between ligand and
receptor was observed (data not shown). Ligand-
receptor interactions were initially detected at or near
the plasma membrane (Figure 7A), but several minutes
later interactions were detected in the cell interior as
well (Figure 7B). By 15 min of incubation, large aggre-
gates of transferrin/TfR1-PCP complexes were clearly
seen (Figure 7C), indicating collection of these com-
plexes in the recycling endosomes. Because of the dis-
tance dependence implicit in FRET measurements, FRET
studies offer a much higher spatial resolution (nm) than
conventional confocal microscopy studies. While in vi-
tro biochemical studies have suggested that transferrin
remains bound to its receptor during its endocytic and
exocytic cycle, our FRET images provide definitive evi-
dence of the bound ligand-receptor complex in living
cells.Significance
Fluorescence imaging of living cells allows the visu-
alization of spatial and temporal dynamics of target
proteins in a live biological context. Successful fluo-
rescence imaging depends on an efficient and spe-
cific method for labeling the target cellular protein
with fluorophores. Here we show that Sfp phospho-
pantetheinyl transferase catalyzes the labeling of cell
surface receptors fused to 80 residue peptide carrier
protein (PCP) with high efficiency and specificity, and
that small molecules of diverse structures can be
used for protein labeling by Sfp. Furthermore our
study demonstrates several key advantages of using
the Sfp-catalyzed protein labeling reaction to target
cell surface protein-PCP fusions. First, Sfp catalyzes
covalent labeling of the PCP-tagged membrane pro-
tein with high efficiency. Sufficient labeling is achieved
on cell lysates or on the living cell within 10 to 20 min.
This feature enables the target protein to be rapidly
labeled and cellular events to be tracked in real time.
Second, as shown by this study and previous studies
[12, 13], the PCP tag of relatively small size (80 resi-
dues) can be fused to many target proteins at either
the N- or C-terminal without significantly disturbing
protein function. Third, Sfp-catalyzed PCP labeling is
compatible with a variety of different small molecules
presented as CoA derivatives, such as biotin and
Alexa Fluor fluorescent dyes. Posttranslational modi-
fication of PCP domains in fusion proteins can be
adopted for affinity purification, live-cell imaging, and
other applications. As shown here, Sfp-catalyzed PCP
labeling is fully compatible with live-cell fluorescence
imaging and single-cell FRET measurements for the
real-time visualization of ligand-receptor interactions.
Experimental Procedures
Cloning
A NotI restriction site was introduced at the end of the TfR1 gene
before the stop codon in plasmid pcDNA3.1(+) TFR with primers
Jun91 (5#- CTC GAG ATA CAG CTG TGC GGC CGC AAA CTC ATT
GTC AAT GTC C), Jun92 (5#- GCG GCC GCA CAG CTG TAT CTC
GAG TAA ATG TGA TAC CCA TAG C), Jun93 (5#- CAC TAG TCC
AGT GTG GTG G) and Jun94 (5#- AGG GCG ATG GCC CAC TAC
Chemistry & Biology
1004Figure 6. FRET Analysis of Transferrin-TfR1
Interactions in TRVb Cells Transfected with
TfR1-PCP
TfR1 was fluorescently labeled with CoA-
Alexa Fluor 488 (2), and cells were then incu-
bated with Tf-Alexa 568 for 2 min. Shown are
images of TfR1-PCP/CoA-Alexa Fluor 488 (2)
before (A) and after (B), and Tf-Alexa 568 be-
fore (C) and after (D), photobleaching of the
acceptor fluorophore Alexa Fluor 568. (E)
Shows the calculated relative intensity of
FRET between donor and acceptor fluoro-
phores, and (F) represents the overlay of (B)
(red), (C) (green), and (E) (blue). (G) Linescan
results by MetaMorph. Fluorescence inten-
sities of the donor (red) and the acceptor
(green) were measured along the line drawn
in (F). Calculated FRET intensity along the
same line (blue) was present only where both
donor and acceptor fluorophores were pres-
ent. Scale bar = 10 µm.G). PCR fragments were first amplified by Jun91 paired with Jun93
and by Jun92 paired with Jun94 from pcDNA3.1(+) TFR, and then
the two amplified fragments were assembled by overlap extension
PCR with primers Jun93 and Jun94. The assembled PCR fragment
was cloned into pcDNA3.1(+) TFRC between the restriction sites
EcoRI and DraIII to give plasmid pcDNA3.1(+) TfR1/NotI, with the
NotI restriction site at the end of the TfR1 gene. The PCP gene was
amplified from plasmid pPheATE [12] with primers Jun97 (5#- GAG
GAG AAA TTA GCG GCC GCA GAA CCT GAT TTA ACT TTC G) and
Jun127 (5#- TTA GTG ATG GTG ATG GTG TCT AGA TTA TTT ACT
ATC TTT TAT ATA TTG), and cloned into plasmid pcDNA3.1(+) TfR1/
NotI between the NotI site and the XbaI site to give plasmid
pcDNA3.1(+) TfR1-PCP.
Synthesis
Synthesis of Biotin-CoA (1) was previously reported [12]. Alexa 488-
CoA (2) was synthesized following a similar procedure. Briefly, to a
solution of Alexa Fluor 488 C5 maleimide (A10254; Molecular
Probes) (1.0 mg, 1.4 mol) in 0.25 ml DMSO, coenzyme A trilithium
salt (Sigma, St. Louis, MO) (1.6 mg, 2.1 mol) in 0.75 ml sodium
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thosphate 100 mM, pH 7.0, was added and the reaction mixture
as stirred at room temperature for 1 hr in darkness. The reaction
ixture was then purified by preparative HPLC on a reverse-phase
18 column with a gradient of 0%–50% acetonitrile in 0.1% TFA/
ater over 30 min. The purified compound was lyophilized, and the
dentity was confirmed by MALDI-TOF (negative mode): calculated
or C51H61N11O28P3S3−: 1465.21; found 1464.28.
eneration of Stable TfR1-PCP Cell Line
RVb cells (a kind gift of Dr. Timothy E. McGraw, Weill Medical
ollege, Cornell University) were grown to 60% confluency in Hams
12 medium containing 50 U/ml penicillin, 50 g/ml streptomycin,
nd 10% fetal bovine serum (FBS) (supplemented Hams F12). The
ells were cotransfected with pcDNATfR1-PCP and pBABEPuro
carrying a puromycin resistance gene) at a 20:1 ratio using Fu-
ENE 6 (Roche Diagnostics, Indianapolis, IN) according to the
anufacturer’s instructions. After allowing 48 hr for gene expres-
ion, selection was performed by adding 30 g/ml puromycin to
he culture medium. After stable selection under these restrictive
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1005Figure 7. Time Course of FRET Redistribution in TRVb Cells during
Transferrin Uptake
TRVb cells were transfected with TfR1-PCP, labeled with CoA-
Alexa Fluor 488 (2), and incubated with Tf-Alexa 568. Images were
calculated from data collected at incubation times of 2 min (A), 5
min (B), and 15 minutes (C). Scale bar = 10 µm.growth conditions, cells were subsequently grown in supplemented
Hams F12 containing 10 g/ml puromycin.
Biotin Labeling and Western Blotting
TRVb1 and TRVb/TfR1-PCP cells were grown to 80% confluency
in Hams F12 medium containing 50 U/ml penicillin, 50 g/ml strep-
tomycin, and 10% FBS. For biotin labeling, cell medium was sup-
plemented with or without 1 M biotin-CoA (1) and 0.5 M Sfp, and
incubation was continued at 30°C for 20 min. Cells were then
washed three times with phosphate-buffered saline (PBS) and
lysed. To detect biotin labeling, cell lysates containing 2 µg protein
were loaded on a 4%–15% SDS-PAGE gel (Biorad, Hercules, CA).
After electrophoresis, the protein bands were electroblotted onto a
piece of PVDF membrane (Biorad). The membrane was then
blocked with 3% bovine serum albumin (BSA) in Tris-buffered sa-
line (TBS) for 2 hr, followed by incubation with 0.1 µg/ml streptavi-
din-HRP conjugate (Pierce, Rockford, IL) in 1% BSA for 1 hr. The
membrane was then washed five times with 0.05% Tween 20 and
0.05% Triton X-100 in TBS, followed by five washes in TBS alone.
Streptavidin binding was detected using an ECL luminescence de-tection kit (Amersham Pharmacia, Piscataway, NJ). For Western
blotting of TfR1 and TfR1-PCP fusion, TRVb/TfR1-PCP and TRVb
cells were lysed in 1% Triton X-100, 10 mM Tris, pH 7.4, 150 mM
NaCl, and 5 mM EDTA containing protease inhibitors, and cell ly-
sates (1 µg) were electrophoresed under reducing conditions as
described above. After transfer, blots were blocked with 5% nonfat
milk in TBS containing 0.1% Tween 20 (TBST) and incubated with
anti-TfR antibody (Invitrogen, Carlsbad, CA) at a 1:1000 dilution in
TBST. After washing four times in TBST, the membrane was incu-
bated with goat anti-mouse-HRP (Pierce) at 1:10,000 in TBST con-
taining 5% nonfat milk. The membrane was then washed four times
with TBS and developed using chemiluminescence (West Pico re-
agent, Pierce).
Uptake of 55Fe-Transferrin in Stable Cell Lines
TRVb, TRVb1 and TRVb/TfR1-PCP cells were grown to 80% conflu-
ency in supplemented Hams F12 medium. After washing twice in
serum-free medium, cell monolayers were incubated in serum-free
Hams F12 medium supplemented with 1% BSA, and 40 nM 55Fe-
transferrin was added for 4 hr at 37°C. 55Fe uptake was quenched
by chilling the cells on ice. After washing three times with ice-cold
PBS, containing 1 mM MgCl2 and 0.1 mM CaCl2 (PBS++), cells
were incubated on ice with 40 g/ml unlabeled Fe-transferrin in 25
mM HEPES, pH 7.4, 150 mM NaCl, and 1 mg/ml BSA for 1 hr to
displace surface bound 55Fe-Tf. Cells were then washed three
times with ice-cold PBS++ and lysed with solubilization buffer
(0.1% Triton X-100, 0.1% NaOH). Cell-associated radioactivity was
determined by liquid scintillation counting, and cell protein was
measured using the Bradford assay to calculate pmol Fe/mg
protein.
125I-Transferrin Cell Surface Binding in Stable Cell Lines
TRVb1 and TRVb-TfR1-PCP cells were grown to 80% confluency
in supplemented Hams F12. Cells were chilled on ice for 15 min
and washed twice in ice-cold serum-free Hams F12 medium. Cell
monolayers were incubated on ice in serum-free Hams F12 medium
containing 20 mM HEPES, pH 7.4, 2 mg/ml ovalbumin, and 0.05–
500 nM 125I-transferrin with or without 2.5 M unlabeled Tf. After
incubation on ice for 2 hr, cells were washed 4 times with PBS++
and lysed with solubilization buffer. Cell-associated radioactivity
was measured by γ counting. To calculate specific cell surface
binding, the amount of radioactivity associated with the cells in the
presence of unlabeled ligand was subtracted from values obtained
in the presence of labeled ligand alone. Data were normalized to
maximal values measured at 500 nM 125I-transferrin for each cell
line.
Transient Transfection
For each 35 mm well in a 6-well plate, one vial of tranfection me-
dium was prepared, containing 3 µl of FuGENE 6 transfection rea-
gent (Roche Diagnostics Corporation) and 1 µg of the relevant plas-
mid diluted in 100 µl of a 1:1 mixuture of Dulbecco minimal
essential media and Hams F12. Transfection medium was mixed
well and allowed to sit for 20 min to come to equilibrium. TRVb
cells were grown on sterilized coverslips to 50%–60% confluency,
incubated with transfection medium for 5 hr, and then incubated in
regular cell media (with serum) for 24 hr to allow time for protein ex-
pression.
Live-Cell Fluorescent Labeling of TfR1-PCP
Cells transfected with TfR1-PCP were incubated in serum-free me-
dia for 2 hr prior to labeling. To label TfR1-PCP, cells were then
incubated with 0.5 µM Sfp and 1 µM CoA-Alexa Fluor 488 (2) in
serum-free media for 30 min at 37°C. Labeled cells were washed
three times with PBS and reimmersed in media. If needed, cells
were then incubated with 10 µg/ml Alexa Fluor 568-conjugated
transferrin (Molecular Probes Inc.) for various time periods and
washed three times with PBS. Cells were then fixed using a 3.7%
formaldehyde solution in PBS, and mounted with SlowFade Anti-
fade Kit (Molecular Probes Inc.) for optical microscopy studies.
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Confocal microscopy analysis of samples was performed using a
Nikon TE2000U inverted microscope in conjunction with a Perkin-
Elmer Ultraview spinning disk confocal system equipped with a Ha-
mamatsu Orca ER Cooled-CCD camera. Images were acquired
using a 60× differential interference contrast (DIC) oil immersion
objective lens, and analyzed using Metamorph software from Uni-
versal Imaging, Inc (Molecular Devices, Downingtown, PA). Where
applicable, images were processed by MetaMorph using 2D no
neighbors deconvolution before 3D reconstruction. For FRET mea-
surements, two images were acquired in each field of view in the
Alexa Fluor 488 (donor) and Alexa Fluor 568 (acceptor) channels
using laser confocal microscopy. The field was then bleached with
intense light at 568 nm from an Hg arc lamp for 60 s, and a second
set of images were acquired. The four images were then processed
and relative FRET intensities were calculated based on protocols
previously described [26]. Experiments were performed three times
with equivalent results, and representative images are shown.
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